Atlas Trials

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Clinical trial NCT03017573 · RECRUITING

Trial details

NCT number
NCT03017573
Sponsor
Institut Curie
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Ovarian CancerTriple-Negative Breast CancerHead and Neck CancerCervical CancerSarcomaVulva Cancer
Start date
2017-01-06
Primary completion
2029-08-06
Enrollment
1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.